Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Clinical Study of Arfolitixorin in Patients With mCRC — Stella

Home/Metastatic Colorectal Cancer (mCRC)/A Clinical Study of Arfolitixorin in Patients With mCRC

View on ClinicalTrials.gov

Recruiting

Back to Metastatic Colorectal Cancer (mCRC) trials

A Clinical Study of Arfolitixorin in Patients With mCRC

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Germany

Charité - Universitaetsmedizin Berlin, Berlin

Key details

Phase

Early testing / Safety & dosing

Sponsor

Isofol Medical AB

Collaborators

Charite University, Berlin, Germany

Enrollment target

~60 participants

Started

April 2025

Primary completion

March 2028

Age range

18 Years and older

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.